Completed PHASE4 INTERVENTIONAL NCT00368862

Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.

Phase Four Double-Blind Randomized Comparative Study on Thestudy on the Efficacy of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism

Sponsor: Finnish Foundation for Alcohol Studies

Conditions Alcoholism Depression

Interventions Cipralex (escitalopram) Ebixa (memantine hydrochloride)

Updated 5 times since 2017 Last updated: Aug 28, 2006 Started: Dec 31, 2005 Completion: Jun 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Alcoholism and Depression and is currently completed. Finnish Foundation for Alcohol Studies leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Sep 2020 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Sep 2020 [monthly]

Completed PHASE4

First recorded

Dec 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Finnish Foundation for Alcohol Studies
Finnish Institute for Health and Welfare

Data source: Finnish Institute for Health and Welfare

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Helsinki, Finland